Blueprint Medicines Corp Stock Price Prediction

Intrinsic Valuation Low Real High 91.71 94.28 96.85 Details

Naive Forecast Low Next High 85.52 88.08 90.65 Details

20 Analysts Consensus Low Target High 67.93 74.65 82.86 Details

Earnings Estimates (0) Low Projected EPS High -0.91 -0.35 -0.21 Details

Blueprint Medicines After-Hype Price Prediction Density Analysis

Blueprint Medicines Estimiated After-Hype Price Volatility

Blueprint Medicines Stock Price Prediction Analysis

Expected Return	Period Volatility	Hype Elasticity	Related Elasticity	News Density	Related Density	Expected Hype
0.02	2.59	0.03	0.00	8 Events / Month	3 Events / Month	In about 8 days

Latest traded price	Expected after-news price	Potential return on next major news	Average after-hype volatility
94.15	96.62	0.00	150.58   Notes

Blueprint Medicines Hype Timeline

Blueprint Medicines Corp is currently traded for 94.15. The entity has historical hype elasticity of -0.03, and average elasticity to hype of competition of 0.0. Blueprint is expected not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is about 150.58%. The immediate return on the next news is expected to be very small, whereas the daily expected return is currently at 0.02%. %. The volatility of related hype on Blueprint Medicines is about 1842.32%, with the expected price after the next announcement by competition of 94.15. About 99.0% of the company shares are held by institutions such as insurance companies. The company recorded a loss per share of 2.09. Blueprint Medicines Corp had not issued any dividends in recent years. Given the investment horizon of 90 days the next expected press release will be in about 8 days. Check out Blueprint Medicines Basic Forecasting Models to cross-verify your projections.

Blueprint Medicines Related Hype Analysis

Blueprint Medicines Additional Predictive Modules

Most predictive techniques to examine Blueprint price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Blueprint using various technical indicators. When you analyze Blueprint charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

The successful prediction of Blueprint Medicines stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Blueprint Medicines Corp, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Blueprint Medicines based on analysis of Blueprint Medicines hews, social hype, general headline patterns, and widely used predictive technical indicators.

The number of cover stories for Blueprint Medicines depends on current market conditions and Blueprint Medicines' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Blueprint Medicines is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Blueprint Medicines' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Blueprint Medicines' future price predictability will typically decrease when Blueprint Medicines' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Blueprint Medicines Corp often depends not only on the future outlook of the potential Blueprint Medicines' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Blueprint Medicines' indicators that are reflective of the short sentiment are summarized in the table below.

When running Blueprint Medicines' price analysis, check to measure Blueprint Medicines' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Blueprint Medicines is operating at the current time. Most of Blueprint Medicines' value examination focuses on studying past and present price action to predict the probability of Blueprint Medicines' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Blueprint Medicines' price. Additionally, you may evaluate how the addition of Blueprint Medicines to your portfolios can decrease your overall portfolio volatility.